Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Famciclovir for the management of genital herpes simplex in patients with inadequate response to aciclovir or valaciclovir.

Literature DB >> 17532725

Famciclovir for the management of genital herpes simplex in patients with inadequate response to aciclovir or valaciclovir.

Stephen L Sacks¹, Fred Y Aoki.

Abstract

Entities: Chemical Species

Year: 2005 PMID： 17532725 DOI： 10.2165/00044011-200525120-00006

Source DB: PubMed Journal: Clin Drug Investig ISSN： 1173-2563 Impact factor: 2.859

× No keyword cloud information.

31 in total

1. Continuous infusion of high-dose acyclovir for serious herpesvirus infections.

Authors: C V Fletcher; J A Englund; B Bean; B Chinnock; D M Brundage; H H Balfour
Journal: Antimicrob Agents Chemother Date: 1989-08 Impact factor: 5.191

2. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy.

Authors: W H Burns; R Saral; G W Santos; O L Laskin; P S Lietman; C McLaren; D W Barry
Journal: Lancet Date: 1982-02-20 Impact factor: 79.321

3. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.

Authors: R C Reichman; G J Badger; G J Mertz; L Corey; D D Richman; J D Connor; D Redfield; M C Savoia; M N Oxman; Y Bryson
Journal: JAMA Date: 1984-04-27 Impact factor: 56.272

4. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

Authors: F Diaz-Mitoma; R G Sibbald; S D Shafran; R Boon; R L Saltzman
Journal: JAMA Date: 1998-09-09 Impact factor: 56.272

5. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.

Authors: S L Sacks; F Y Aoki; F Diaz-Mitoma; J Sellors; S D Shafran
Journal: JAMA Date: 1996-07-03 Impact factor: 56.272

6. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.

Authors: T Schacker; H L Hu; D M Koelle; J Zeh; R Saltzman; R Boon; M Shaughnessy; G Barnum; L Corey
Journal: Ann Intern Med Date: 1998-01-01 Impact factor: 25.391

Famciclovir for the management of genital herpes simplex in patients with inadequate response to aciclovir or valaciclovir.

1. Continuous infusion of high-dose acyclovir for serious herpesvirus infections.

2. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy.

3. Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.

4. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

5. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.

6. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.

7. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.

Review 8. Herpesvirus infections in persons infected with human immunodeficiency virus.

9. Treatment of resistant herpes simplex virus with continuous-infusion acyclovir.

Review 10. Pharmacokinetics of acyclovir after intravenous and oral administration.

Review 1. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.